Viewing nowGlidia Tablet 15 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dasan Pharmaceutical Co., Ltd.

MFDS item code 201802982 · Approved 2018.07.18 · Insurance code 678601100
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to assist patients with type 2 diabetes in controlling their blood glucose levels. It can be administered alone or in combination with other medications along with dietary adjustments and exercise therapy. This helps in effectively managing blood glucose and reducing the risk of complications, contributing to maintaining a healthier blood glucose state in patients' daily lives. This medication improves blood glucose control in type 2 diabetes.
This medicine is administered orally once daily, with or without food. Clinically, this medicine should be administered for an appropriate period (at least 3 months) to evaluate changes in glycated hemoglobin in patients with diabetes, provided that glycemic control does not worsen. 1. Monotherapy In patients whose blood glucose is not adequately controlled with diet and exercise, this medicine may be initiated as monotherapy at 15 mg of pioglitazone once daily. If an adequate effect is not achieved with the initial dose of this medicine, the dose may be increased to up to 30 mg once daily. 2. Combination therapy 1) Sulfonylureas: This medicine may be administered in combination with a sulfonylurea. The initial dose is 15 mg once daily. When used in combination with this medicine, the current sulfonylurea may be continued at the same dose and regimen. However, if the patient experiences symptoms of hypoglycemia, the sulfonylurea dose should be reduced. 2) Metformin: This medicine may be administered in combination with metformin. The initial dose is 15 mg once daily. When used in combination with this medicine, the current metformin may be continued at the same dose and regimen. It is unlikely that the metformin dose will need to be adjusted because of hypoglycemic symptoms during combination therapy with this medicine. 3) Insulin: This medicine may be administered in combination with insulin at a dose of 15 mg once daily. The current insulin dose may be maintained when combination therapy with this medicine is initiated. However, if a patient receiving this medicine in combination with insulin experiences symptoms of hypoglycemia or the plasma glucose concentration decreases to 100 mg/dL or below, the insulin dose may be reduced by 10 ~ 25 %. Subsequent dose adjustments should be individualized according to glycemic control. Maximum recommended dose For monotherapy or combination therapy with a sulfonylurea, metformin, or insulin, doses exceeding 30 mg once daily are not recommended. Dose adjustment is not recommended in patients with renal impairment (see Renal Impairment under General Precautions). Therapy with this medicine should not be initiated if, at the time of treatment initiation, the patient has clinical evidence of active liver disease or elevated serum aminotransferase levels (≥2.5 times the upper limit of normal for ALT) (see Effects on the Liver under Adverse Reactions and General Precautions). Liver enzyme monitoring is recommended in all patients before starting therapy with this medicine and periodically thereafter.
Under 18 years of age: Use is not recommended because there is no experience with this medicine.
This medication is used to help patients with type 2 diabetes control their blood glucose levels. While taking this medication, heart disease known as congestive heart failure may develop or worsen, so if symptoms of heart failure occur, immediate medical attention should be sought. Patients with heart failure or a history of heart failure should not use this medication. This medication may cause fluid retention, worsening edema or heart failure, so if symptoms of edema occur, a consultation with a doctor is necessary. This medication should not be administered to patients with active bladder cancer or a history of bladder cancer. Patients with severely impaired liver or kidney function should not use this medication, and those with liver dysfunction should undergo regular liver function tests. Women who are pregnant or may become pregnant should not take this medication, and premenopausal women should use appropriate contraception as ovulation may be stimulated, increasing the risk of pregnancy. When used in combination with other hypoglycemic agents or insulin, the risk of hypoglycemia may increase, so when concomitant administration is performed, pay attention to hypoglycemic symptoms and adjust the dosage of other medications as necessary. Elderly patients or those with cardiovascular diseases should use this medication with caution; especially patients over 75 years old should take it cautiously. If any symptoms such as weight gain, edema, difficulty breathing, or sudden weight changes occur while taking this medication, patients should inform their healthcare provider immediately. Additionally, this medication may cause side effects such as liver dysfunction, hypoglycemia, edema, headache, upper respiratory infections, so if abnormal symptoms occur, a prompt consultation with a doctor is advised. Long-term use of this medication may increase the risk of bone fractures, making it important to regularly check bone health status. Finally, this medication has not been confirmed for safety and efficacy in children, so it is not used.
Congestive heart failure, excessive and rapid weight change, dyspnea, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, back pain, dizziness, diarrhea, increased serum creatine kinase, hypertension, heart failure, limb pain, chest pain, cardiovascular abnormalities, heart failure, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, dizziness, appetite loss, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, dyspnea, pruritus, chest discomfort, trembling, chills, gastrointestinal disease, abdominal pain, epigastric discomfort, paresthesia, muscle rigidity, discomfort in the head, increased liver enzymes, worsening liver disease, urticaria, eczema, arthralgia, knee issues, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, hypertension, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, abdominal pain, heart failure, adverse reactions related to edema, liver failure, macular edema, fracture, weight gain, increased serum ALT levels, increased serum bilirubin levels, hematological changes (decreased hemoglobin and hematocrit), increased serum creatine kinase
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a special container to avoid exposure to light and air. Also, avoid humid places, and it is recommended to store it at a temperature between 15 to 30 degrees Celsius, preferably around 25 degrees.
White to off-white round and convex tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dasan Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.